Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Ulmer

Showing results (121-130 of 174) with videos related to

Pageof 18
Sort By:
Vaccines|September 8, 2015
Enhanced Delivery and Potency of Self-Amplifying mRNA Vaccines by Electroporation in SituYen Cu, Kate E Broderick, Kaustuv Banerjee, et al.
Vaccine|January 29, 2000
Enhanced type I immune response to a hepatitis B DNA vaccine by formulation with calcium- or aluminum phosphateS Wang, X Liu, K Fisher, et al.
Novartis Foundation Symposium|February 9, 1999
DNA vaccines against tuberculosisJ B Ulmer, D L Montgomery, A Tang, et al.
Frontiers in Immunology|March 5, 2025
Dynamics of spike-specific neutralizing antibodies across five-year emerging SARS-CoV-2 variants of concern reveal conserved epitopes that protect against severe COVID-19Latifa Zayou, Swayam Prakash, Hawa Vahed, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
Dynamics of Spike-Specific Neutralizing Antibodies Across Five-Year Emerging SARS-CoV-2 Variants of Concern Reveal Conserved Epitopes that Protect Against Severe COVID-19Latifa Zayou, Swayam Prakash, Hawa Vahed, et al.
Molecular Medicine (Cambridge, Mass.)|June 1, 1997
Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytesT M Fu, J B Ulmer, M J Caulfield, et al.
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 29, 2000
Immunogenicity and protective efficacy of DNA vaccines encoding secreted and non-secreted forms of Mycobacterium tuberculosis Ag85AS L Baldwin, C D D'Souza, I M Orme, et al.
Vaccine|October 21, 1998
Immunogenicity and efficacy of DNA vaccines encoding influenza A proteins in aged miceB S Bender, J B Ulmer, C M DeWitt, et al.
DNA and Cell Biology|November 1, 1993
Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectorsD L Montgomery, J W Shiver, K R Leander, et al.
Vaccine|August 18, 2004
Enhanced protective efficacy of a tuberculosis DNA vaccine by adsorption onto cationic PLG microparticlesHans-Joachim Mollenkopf, Guido Dietrich, Joachim Fensterle, et al.
Pageof 18

Showing results (121-130 of 174) with videos related to

Sort By:
Pageof 18
Vaccines|September 8, 2015
Enhanced Delivery and Potency of Self-Amplifying mRNA Vaccines by Electroporation in SituYen Cu, Kate E Broderick, Kaustuv Banerjee, et al.
Vaccine|January 29, 2000
Enhanced type I immune response to a hepatitis B DNA vaccine by formulation with calcium- or aluminum phosphateS Wang, X Liu, K Fisher, et al.
Novartis Foundation Symposium|February 9, 1999
DNA vaccines against tuberculosisJ B Ulmer, D L Montgomery, A Tang, et al.
Frontiers in Immunology|March 5, 2025
Dynamics of spike-specific neutralizing antibodies across five-year emerging SARS-CoV-2 variants of concern reveal conserved epitopes that protect against severe COVID-19Latifa Zayou, Swayam Prakash, Hawa Vahed, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
Dynamics of Spike-Specific Neutralizing Antibodies Across Five-Year Emerging SARS-CoV-2 Variants of Concern Reveal Conserved Epitopes that Protect Against Severe COVID-19Latifa Zayou, Swayam Prakash, Hawa Vahed, et al.
Molecular Medicine (Cambridge, Mass.)|June 1, 1997
Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytesT M Fu, J B Ulmer, M J Caulfield, et al.
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 29, 2000
Immunogenicity and protective efficacy of DNA vaccines encoding secreted and non-secreted forms of Mycobacterium tuberculosis Ag85AS L Baldwin, C D D'Souza, I M Orme, et al.
Vaccine|October 21, 1998
Immunogenicity and efficacy of DNA vaccines encoding influenza A proteins in aged miceB S Bender, J B Ulmer, C M DeWitt, et al.
DNA and Cell Biology|November 1, 1993
Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectorsD L Montgomery, J W Shiver, K R Leander, et al.
Vaccine|August 18, 2004
Enhanced protective efficacy of a tuberculosis DNA vaccine by adsorption onto cationic PLG microparticlesHans-Joachim Mollenkopf, Guido Dietrich, Joachim Fensterle, et al.
Pageof 18